Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cells
Conclusions
Together, these findings implicate PDK4 as a critical metabolic regulator of EMT and associated drug resistance.
Source: Cancer and Metabolism - Category: Cancer & Oncology Source Type: research